Company / Working Capital per Share
Sonoma Pharmaceuticals, Inc. Working Capital per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$10.96
FY2025
5-year range
$1.79 / $10.96
FY2021-FY2025
Trend
+512.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share changed +512% YoY in FY2025, a notable deviation from the 8-year average annual change of +82%.
Based on SEC 10-K filings.
10.96 in FY2025 with a 5-year CAGR of +13.9%.
Improved from $3.25 to $10.96 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +29.3%
- 5-Year CAGR
- +13.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital per share increased 512.4% year-over-year.
- Peak working capital per share was recorded in FY2019.
- Lowest working capital per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | - | - |
| FY2025 | $10.96 | +512.4% |
| FY2024 | $1.79 | -45.0% |
| FY2023 | $3.25 | -35.9% |
| FY2022 | $5.07 | +1.2% |
| FY2021 | $5.01 | -12.3% |
| FY2020 | $5.71 | -56.0% |
| FY2019 | $12.99 | +328.7% |
| FY2018 | $3.03 | -34.3% |
| FY2017 | $4.61 | +643.1% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026